| ASSET | QUARTER | % RETURN |
|---|---|---|
Mesoblast (MESO) | Q1 2010 | 101,090.48% |
Electrovaya (ELVA) | Q1 2010 | 2,033.56% |
BioRestorative Therapies (BRTX) | Q1 2010 | 592.31% |
BOS Better Online Solutions (BOSC) | Q1 2010 | 377.01% |
Wabash National (WNC) | Q1 2010 | 274.86% |
Coda Octopus (CODA) | Q1 2010 | 246.15% |
Versus Systems Inc. (VS) | Q1 2010 | 240% |
Paysign (PAYS) | Q1 2010 | 200% |
AGIG (AGIG) | Q1 2010 | 192.86% |
Theriva Biologics (TOVX) | Q1 2010 | 192.42% |
Zivo Bioscience (ZIVO) | Q1 2010 | 190% |
Eva Live Inc Common Stock (GOAI) | Q1 2010 | 150% |
Intrusion (INTZ) | Q1 2010 | 145.95% |
Opus Genetics (IRD) | Q1 2010 | 145.45% |
Empire Petroleum (EP) | Q1 2010 | 134.26% |
Novanta (NOVT) | Q1 2010 | 132.94% |
Aurinia Pharmaceuticals (AUPH) | Q1 2010 | 120.86% |
Arrowhead Pharmaceuticals (ARWR) | Q1 2010 | 115.09% |
Ridgetech (RDGT) | Q1 2010 | 114.29% |
Radian (RDN) | Q1 2010 | 107.49% |
MIND CTI (MNDO) | Q1 2010 | 106.54% |
SUI (SUIG) | Q1 2010 | 100% |
Netcapital (NCPL) | Q1 2010 | 100% |
VerifyMe (VRME) | Q1 2010 | 100% |
Red Cat (RCAT) | Q1 2010 | 100% |